pharmaphorum

FEBRUARY 17, 2021

John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. . “The market” was terrified when Warren Buffett, Jamie Dimon and Jeff Bezos got together to disrupt healthcare three years ago with the launch of Haven – in response to that news, healthcare stocks comprising a significant chunk of the $3.5 trillion health economy in the United States shed billions in value overnight.

Online Pharmacies 124

Online Pharmacies Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 124

Outsourcing Pharma

FEBRUARY 15, 2021

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

Vaccines 144

Vaccines 144

Pharma Times

FEBRUARY 15, 2021

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial

Vaccines 125

Vaccines 125

Pharma Marketing Network

FEBRUARY 16, 2021

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers.

Communication 98

Communication 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 16, 2021

Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . The alliance will see Exscientia work with the charity’s Oxford Drug Discovery Institute (ODDI) to find therapeutics that target the neuroinflammation associated with Alzheimer’s disease (AD), focusing in particular on the NLRP3 inflammasome pathway.

Diabetes 117

Diabetes Immunity Immunization 117

Outsourcing Pharma

FEBRUARY 15, 2021

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

Drug Development 116

Drug Development 116

NY Times

FEBRUARY 16, 2021

A health journalist is getting a front-row seat to one of the most-anticipated pediatric trials in history.

Vaccines 96

Vaccines Immunity Immunization 96

pharmaphorum

FEBRUARY 19, 2021

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development. The move will also see ex-Pfizer digital medicine executive Dr Daniel Karlin join the MindMed executive team, along with former Google AI guru Bradford Cross.

Drug Development 112

Drug Development 112

Outsourcing Pharma

FEBRUARY 16, 2021

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

105

105

Pharma Times

FEBRUARY 15, 2021

Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community

121

121

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

FEBRUARY 16, 2021

Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Genus Lifesciences drug GOPRELTO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

FEBRUARY 16, 2021

A news agency is claiming that North Korea launched a cyber-attack on Pfizer in a bid to steal information about its BioNTech-partnered COVID-19 vaccine, citing South Korea’s National Intelligence Service (NIS). The Yonhap agency said the revelation was made during a closed-door meeting of the intelligence committee of South Korea’s National Assembly.

Vaccines 109

Vaccines Hospitals 109

Outsourcing Pharma

FEBRUARY 18, 2021

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Drug Development 98

Drug Development Vaccines 98

Pharma Times

FEBRUARY 18, 2021

New report recommends continuing collaborations across the life sciences sector

133

133

Drug Patent Watch

FEBRUARY 19, 2021

Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Janssen Biotech drug BALVERSA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 19, 2021

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues. Once someone is infected with HIV it stays with them for life thanks to the retrovirus’s ability to inject its DNA code into the host. Snipping out this viral code with powerful CRISPR gene editing technology, which last year won Drs Emmanuelle Charpentier and Jennifer Doudna the Nobel Prize for chemistry

104

104

Outsourcing Pharma

FEBRUARY 16, 2021

A leader from the clinical data solutions firm explains how the challenges created by the pandemic have helped fuel creativity and innovation in studies.

95

95

Pharma Times

FEBRUARY 18, 2021

Series C financing will also be used for the development of Evox's DeliverEX exosome drug platform

105

105

Pharma Mirror

FEBRUARY 19, 2021

Methods to Improve Mind, Body, and Spirit At a certain point, most people deal with obstacles to their health or wellness caused by aging, trauma, or the regular stressors of modern life. This past year in particular has been hard in the wake of COVID-19. Now more than ever, people are trying to find natural ways to improve their mental, physical, and spiritual wellbeing that don’t involve a doctor’s visit.

52

52

pharmaphorum

FEBRUARY 17, 2021

Roche’s Italian subsidiary has joined forces with digital health startup PatchAi to roll out an app that aims to support people diagnosed with cancer. Roche and PatchAi have been working together on the Smart Health Companion (SHC), which was launched to oncology and haematology patients in July 2020, and will now step up their collaboration to offer it more widely.

Communication 104

Communication 104

Outsourcing Pharma

FEBRUARY 18, 2021

The two companies will work to advance precision cancer medicine by harnessing genomics data in trial design, recruitment, site selection and other areas.

90

90

Pharma Times

FEBRUARY 16, 2021

Antibody drug conjugate conditionally approved for HER2-positive metastatic breast cancer

109

109

Drug Patent Watch

FEBRUARY 18, 2021

Annual Drug Patent Expirations for ANNOVERA Annovera is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Therapeuticsmd Inc drug ANNOVERA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 17, 2021

COVID-19 has increased demands on informal carers and severely increased demands on their mental, physical and financial wellbeing, according to a global study. Embracing Carers is a global initiative led by Germany’s Merck KGaA and is focused on recognising and raising awareness about the role of informal carers. It intends to develop solutions with global organisations and has produced the Carer Well-Being Index to provide insights and recommendations to help the public and private sector supp

Communication 98

Communication 98

Outsourcing Pharma

FEBRUARY 18, 2021

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Drug Development 52

Drug Development 52

Pharma Times

FEBRUARY 17, 2021

New data shows overuse of SABA relievers is responsible for 250,000 tonnes of CO2 emissions annually

98

98

Drug Patent Watch

FEBRUARY 18, 2021

Annual Drug Patent Expirations for KATERZIA Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting…. The post New patent for Azurity drug KATERZIA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 18, 2021

Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type worldwide. . The human challenge study has just secured ethics committee approval and will recruit up to 90 volunteers aged 18-30 years, according to the UK government, which is backing it with £33.6 million ($47 million) in funding.

Vaccines 97

Vaccines Immunity Immunization 97

Pharma Mirror

FEBRUARY 18, 2021

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16. BSI is well- positioned to become the industry’s most reliable and cost-effective supplier of GMP quality QS-21 worldwide.

Immunity 52

Immunity Immunization Vaccines 52

Pharma Times

FEBRUARY 17, 2021

A growing number of patients are waiting 52 weeks or more for hospital treatment

Hospitals 103

Hospitals 103

Drug Patent Watch

FEBRUARY 17, 2021

Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There…. The post New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 18, 2021

Nektar Therapeutics is waiting on multiple data readouts for its lead drug bempegaldesleukin paired with strategic partner Bristol-Myers Squibb’s checkpoint inhibitor Opdivo, but that hasn’t stopped it signing up to test the drug with rival Keytruda from Merck & Co. . Merck will pair Keytruda (pembrolizumab) with bempegaldesleukin (NKTR-214) – known as bempeg for short – in a phase 2/3 trial involving patients with squamous cell carcinoma of the head and neck (SCCHN) that if positive could s

95

95

Pharma Marketing Network

FEBRUARY 16, 2021

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers.

Communication 52

Communication 52

Pharma Times

FEBRUARY 19, 2021

AVA6000 is pro-drug form of the chemotherapy doxorubicin, modified using Avacta's pre|CISION chemistry

Chemotherapy 87

Chemotherapy 87

Drug Patent Watch

FEBRUARY 17, 2021

Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca Pharms and is included in two NDAs. It is available from one supplier. There are eleven patents…. The post New patent for Astrazeneca Pharms drug LYNPARZA appeared first on DrugPatentWatch - Make Better Decisions.

52

52